The Economic Impact of Blindness in Europe

ABSTRACT Purpose: To estimate the annual loss of productivity from blindness and moderate to severe visual impairment (MSVI) in the population aged >50 years in the European Union (EU). Methods: We estimated the cost of lost productivity using three simple models reported in the literature based on (1) minimum wage (MW), (2) gross national income (GNI), and (3) purchasing power parity-adjusted gross domestic product (GDP-PPP) losses. In the first two models, assumptions included that all individuals worked until 65 years of age, and that half of all visual impairment cases in the >50-year age group would be in those aged between 50 and 65 years. Loss of productivity was estimated to be 100% for blind individuals and 30% for those with MSVI. None of these models included direct medical costs related to visual impairment. Results: The estimated number of blind people in the EU population aged >50 years is ~1.28 million, with a further 9.99 million living with MSVI. Based on the three models, the estimated cost of blindness is €7.81 billion, €6.29 billion and €17.29 billion and that of MSVI €18.02 billion, €24.80 billion and €39.23 billion, with their combined costs €25.83 billion, €31.09 billion and €56.52 billion, respectively. The estimates from the MW and adjusted GDP-PPP models were generally comparable, whereas the GNI model estimates were higher, probably reflecting the lack of adjustment for unemployment. Conclusion: The cost of blindness and MSVI in the EU is substantial. Wider use of available cost-effective treatment and prevention strategies may reduce the burden significantly.

[1]  S. Resnikoff,et al.  A Simple Method for Estimating the Economic Cost of Productivity Loss Due to Blindness and Moderate to Severe Visual Impairment , 2015, Ophthalmic epidemiology.

[2]  S. Yusuf,et al.  The burden of disease in older people and implications for health policy and practice , 2015, The Lancet.

[3]  E. Boer,et al.  Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients. , 2015, Ophthalmology.

[4]  P. Mitchell,et al.  Visual impairment and the incidence of falls and fractures among older people: longitudinal findings from the Blue Mountains Eye Study. , 2014, Investigative ophthalmology & visual science.

[5]  Seth R Flaxman,et al.  Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990–2010 , 2014, British Journal of Ophthalmology.

[6]  Gretchen A. Stevens,et al.  Causes of vision loss worldwide, 1990-2010: a systematic analysis. , 2013, The Lancet. Global health.

[7]  Gretchen A. Stevens,et al.  Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010. , 2013, Ophthalmology.

[8]  Robert P Finger,et al.  The economic burden of visual impairment and blindness: a systematic review , 2013, BMJ Open.

[9]  E. Nord Disability weights in the Global Burden of Disease 2010: unclear meaning and overstatement of international agreement. , 2013, Health policy.

[10]  H. Taylor,et al.  Disability weights for vision disorders in Global Burden of Disease study , 2013, The Lancet.

[11]  A. Cruess,et al.  The cost of vision loss in Canada. 2. Results. , 2011, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[12]  Yoshimune Hiratsuka,et al.  Economic cost of visual impairment in Japan. , 2010, Archives of ophthalmology.

[13]  H. Taylor,et al.  The cost of visual impairment: purposes, perspectives, and guidance. , 2010, Investigative ophthalmology & visual science.

[14]  K. Naidoo,et al.  Potential lost productivity resulting from the global burden of uncorrected refractive error. , 2009, Bulletin of the World Health Organization.

[15]  R. Klein,et al.  The economic burden of major adult visual disorders in the United States. , 2006, Archives of ophthalmology.

[16]  C. Hyde,et al.  What is the cost of blindness? , 2003, The British journal of ophthalmology.

[17]  B. Jönsson Revealing the cost of Type II diabetes in Europe. , 2002, Diabetologia.

[18]  A. Hofman,et al.  Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning: the Rotterdam Study. , 2001, Archives of ophthalmology.

[19]  J. de Swiet Letter: Therapy for acute diarrhoea. , 1975, Lancet.